Navigation Links
Trovagene, Inc. Reports Third Quarter 2013 Financial Results
Date:11/14/2013

cessful. Trovagene does not undertake an obligation to update or revise any forward-looking statement.  Investors should read the risk factors set forth in Trovagene's Form 10-K for the year ended December 31, 2012 and other periodic reports filed with the Securities and Exchange Commission.

 (Financial Information to Follow)ContactTrovagene, Inc.FinancialInvestor RelationsStephen Zaniboni

Chief Financial OfficerAmy Caterina

Investor RelationsTrovagene, Inc.Trovagene, Inc.858-952-7594858-952-7593szaniboni@trovagene.comacaterina@trovagene.com 

 

  

Trovagene, Inc. and Subsidiaries
(A Development Stage Company)
Selected Financial Information
Consolidated Condensed Statements of Operations and Comprehensive Loss 

(in thousands, except for per share amounts) Three Months Ended
September 30,Nine Months Ended
September 30,2013201220132012(Unaudited)(Unaudited)Revenues$

44$

211$

212$

287Operating expenses:Research and development 9165112,6621,326General and administrative 2,2067395,3922,376Total operating expenses3,1221,2508,0533,702Operating loss(3,078)(1,039)(7,842)(3,415)Interest expense(6)-(7)-Change in fair value of derivative instruments - warrants(1,317)389(2,933) 

(1,824)Net loss and comprehensive loss$

(4,401)$

(650)$

(10,782)$

(5,239)Preferred stock dividend(5)(10)(21)(29)Net loss and comprehensive loss available to common stockholders$

(4,406)$

(660)$

(10,803)$

(5,268)Basic and diluted net loss per share$

(0.25)$

(0.05)$

(0.66)$

(0.42)Weighted average shares outstanding- basic and dilute17,87114,17816,33012,507 

 

 

 

Trovagene, Inc. and Subsidiaries(A Development Stag
'/>"/>

SOURCE Trovagene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
2. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
3. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
4. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
5. Interleukin Genetics Reports Third Quarter 2011 Financial Results
6. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
7. Nile Therapeutics Reports 2011 Third Quarter Financial Results
8. Pharmasset Reports Fiscal Year End 2011 Financial Results
9. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
10. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
11. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014   , ... Officer zu KLOX    ... Financial Officer bestellt    KLOX ist ... jüngst zugelassenen Behandlungssystems zur Wundheilung zu beginnen    , ... ist sehr erfreut, die folgenden personellen Veränderungen anzukündigen: ...
(Date:11/21/2014)... 20, 2014 Author Matthew J. Pallamary’s ... the Other Side” published as a tribute to ... the “Fiction: Short Story” category of the 2014 ... and CEO of USA Book News, said this year’s ... publishers, including Simon & Schuster, Penguin, John Wiley & ...
(Date:11/21/2014)... November 21, 2014 Why did Stephen ... Albert Einstein so instantly recognizable? Why have they become ... astronomer and author Hilton Ratcliffe seeks out the answers ... at all to do with science. In " Stephen ... , November 21, 2014), Ratcliffe puts it plainly: ...
(Date:11/21/2014)... YORK and SAN DIEGO , ... ), today announced that President and CEO Marc Hedrick , ... DATE:   Thursday, December 4, 2014 TIME: ... Click here or paste this URL into your ... recommended that investors pre-register to save time and receive event ...
Breaking Biology Technology:KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 2Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 3Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 4“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 2Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 4
... to ICD and CRT-D ... device ... BSX ) today announced a new clinical science initiative,ALTITUDE, which will ... the substantial LATITUDE data to,seek answers to common questions related to ...
... May 15 Human Genome Sciences,Inc. (Nasdaq: ... has joined the,Company as Vice President, Hepatology Franchise. ... Hematology, Genentech Corporation, will,report to Barry A. Labinger, ... http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ), "Kevin McRaith brings ...
... QUEBEC CITY, May 15 /PRNewswire-FirstCall/ - AEterna Zentaris ... biopharmaceutical company focused on,endocrine therapy and oncology, today ... Officer, Dennis Turpin, CA, will present a,company overview ... Global,Healthcare Conference on Tuesday, May 20, 2008 at ...
Cached Biology Technology:Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 2Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 3Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data 4Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise 2Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise 3AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting 2
(Date:11/21/2014)... C-Labs LLC, a leading provider of remote ... today announced the appointment of John Traynor ... strategic advisor to the firm, Mr. Traynor will now ... based out of the C-Labs office in ... Muench , Chief Executive Officer. Photo - ...
(Date:11/18/2014)... , Nov. 18, 2014  The Secure ... Industry Association today jointly announce the formation of ... release of its Identity and Biometric Entry ... The Framework received official support from BORDERPOL, the ... to improve and provide expertise regarding border security, ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... Atlantic right whale's future looks grim if the current ... professor of oceanography Douglas Nowacek and a group of ... co-authored a paper titled "North Atlantic Right Whales in ... the journal Science. , In it, Nowacek and his ...
... the final step in the completion of new blood vessel ... Diego (UCSD) School of Medicine team in research that promises ... by cutting off the tumor blood supply. , The research ... at UCSD and a member of the Rebecca and John ...
... Scientists may have found a way to dramatically slow ... , That's the promising implication of an animal study ... at Birmingham (UAB) and the University of Florida (UF) ... the National Academy of Sciences. , The research team ...
Cached Biology News:FSU scientist warns North Atlantic right whale facing extinction 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 2Unexpected lock and key mechanism found for the assembly of tumor blood vessels 3Discoveries by UAB and Florida scientists may help transplanted organs survive longer 2
... carry-over contamination, which prevents false positive ... from previous PCR amplifications without degrading ... amplification ,Optimized for use with GeneAmp ... systems , The GeneAmp PCR Carry-over ...
... enzyme that catalyzes the conversion,of starch ... maltotriose and,dextrins. The level of a-amylase ... are of clinical importance,1-3 while plant ... industry.4, The EnzChek Amylase Assay Kit ...
... that catalyzes the hydrolysis of,starch to ... dextrins. The,level of a-amylase in various ... of,clinical significance in the diagnosis of ... and microbial a-amylases are,important enzymes for ...
Rat monoclonal [20d5] to NKG2A + C+ E ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Mouse): CHO transfected cells expressing the B6 allele of NKG2A. Entrez Gen...
Biology Products: